Jeff Saunders
Keine laufenden Positionen mehr
Profil
Jeff Saunders worked as Vice President-Chemistry at Agios Pharmaceuticals, Inc. and as Vice President-Small Molecule Discovery at Ember Therapeutics, Inc. He received an undergraduate degree from Hope College and a doctorate degree from the University of South Carolina.
Ehemalige bekannte Positionen von Jeff Saunders
| Unternehmen | Position | Ende |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Jeff Saunders
| Hope College | Undergraduate Degree |
| University of South Carolina | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |